Reports from Accumark Labs rest on a thin but honest base: the laboratory names concrete instrumentation (LC-MS and NMR) and states plainly that it holds no accreditation, which is the normal case for a lab accepting private samples rather than a red flag. These two positive signals - instrument disclosure and honest non-claim of accreditation - are what the public record supports.
The evidence does not yet converge to a 'Substantiated' rating because no independent public corroboration across additional evidence dimensions has been documented: there is no demonstrated peptide or research-chemical testing offering in the provided signals, no independent performance data, and no community or forum footprint that would broaden the picture beyond the lab's own disclosures. These are neutral limits of the current public evidence, not negative findings.
Separately, no named operating entity, no named personnel, and no external corroboration of the lab's 'independent verification' claim are on record - again, normal for a private-sample lab, not an accusation. No enforcement actions, complaints, or false accreditation claims were found. The open questions are whether operator identity and analytical performance can be independently checked in the future. These are signals, not a verdict.